Lee Helman is the Director of the Osteosarcoma Institute, a nonprofit organization that is dedicated to improving the survival of patients with metastatic or recurrent osteosarcoma.
Dr. Helman has been studying the biology of sarcomas and caring for pediatric patients with sarcomas for over thirty years. He has also trained many investigators in the field of pediatric sarcomas and has received numerous awards for his work. He spent 30 years at the National Cancer Institute in various leadership positions, and recently spent 3 years at Children’s Hospital Los Angeles as head of research in the Cancer and Blood Disease Institute, where he remains an adjunct professor.
Dr. Helman has served on many advisory boards, and served as vice-chair of the Scientific Advisory Board of Stand up To Cancer until 2023. He is currently focusing on improving outcomes in osteosarcoma and serves as the Director of the Osteosarcoma Institute. He is also an editor of the textbook Pizzo and Poplack’s Pediatric Oncology.
